Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis
Anika Kästner, Anna Kron, Neeltje van den Berg, et al.
The Lancet Regional Health - Europe (2023) Vol. 36, pp. 100788-100788
Open Access | Times Cited: 17

Showing 17 citing articles:

The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer
Mary Nesline, Vivek Subbiah, Rebecca A. Previs, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 2, pp. 329-343
Open Access | Times Cited: 7
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors—A Retrospective Molecular Tumor Board Analysis
Niklas Gremke, Fiona R. Rodepeter, Julia Teply‐Szymanski, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1561-1561
Open Access | Times Cited: 4
MAT1A activation of glycolysis to promote NSCLC progression depends on stabilizing CCND1
Shengping Shen, Ruili Liu, Jiazheng Huang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 4
Personalized Cancer Therapy: Advancement in Biomarker-Based Treatment Strategies for Non-Small Cell Lung Cancer
Ubaid ur Rehman, Quratulain Badar, Yasser Hijazi Abdoon, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 675-689
Closed Access
Editorial: Advancements and Challenges in Lung Cancer Screening, Diagnosis, and Management
Yi-Chi Hung, Yun Lin, Fu‐Zong Wu
Diagnostics (2025) Vol. 15, Iss. 7, pp. 835-835
Open Access
Precision medicine and personalized treatment
Harpreet Kaur Channi, Ramandeep Sandhu, Mandeep Kaur, et al.
Elsevier eBooks (2025), pp. 151-174
Closed Access
European screening platform for EORTC clinical trials in advanced colorectal cancer ‘SPECTAcolor’
G. Folprecht, Marie Morfouace, Maike Collienne, et al.
ESMO Gastrointestinal Oncology (2025) Vol. 8, pp. 100168-100168
Closed Access
Deterministic reprogramming and signaling activation following targeted therapy in non-small cell lung cancer driven by mutations or oncogenic fusions
Rafael Rosell, Carlos Pedraz‐Valdunciel, Anisha Jain, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 3, pp. 171-182
Closed Access | Times Cited: 2
COMORBIDITY IN ONCOLOGY: MODERN CHALLENGES AND THE SEARCH FOR WAYS TO SOLVE THE PROBLEM
O.V. Drobotun, Nikolai N. Kolotilov, V.F. Konovalenko, et al.
Clinical and Preventive Medicine (2024), Iss. 3, pp. 132-141
Open Access | Times Cited: 1
Molecular oncology: perspectives for further development
Peter Horak, Stefan Fröhling
Deleted Journal (2024) Vol. 30, Iss. 10, pp. 905-915
Closed Access | Times Cited: 1
Globalization of precision medicine programs in lung cancer: a health system challenge
Christian Rolfo, Valeria Denninghoff
The Lancet Regional Health - Europe (2023) Vol. 36, pp. 100819-100819
Open Access | Times Cited: 2
Personalisierte Medizin bei Lungenkrebs am Beispiel des nationalen Netzwerks Genomische Medizin
Anna Kron, Jürgen Wolf
Forum (2024) Vol. 39, Iss. 1, pp. 53-56
Closed Access
Zielgerichtete Therapie des nichtkleinzelligen Lungenkarzinoms
Franziska Glanemann, Marcel Wiesweg
Deleted Journal (2024) Vol. 30, Iss. 9, pp. 877-885
Closed Access
„Kelch-like ECH-associated protein 1“ (KEAP1)
Matthias Scheffler
Trillium Krebsmedizin (2024) Vol. 33, Iss. 4, pp. 276-281
Closed Access
Plinabulin, a microtubule destabilising agent, in non-small-cell lung cancer: lessons from the DUBLIN-3 trial
Rafael Rosell, María González‐Cao, Miguel Ángel Molina‐Vila
The Lancet Respiratory Medicine (2024)
Closed Access
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
Christoph Arolt, Andreas H. Scheel, Margaret Dugan, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
„Wir brauchen eine sehr enge interdisziplinäre Zusammenarbeit der diagnostischen und therapeutischen Fächer“

best practice onkologie (2023) Vol. 18, Iss. 12, pp. 590-595
Closed Access
Page 1

Scroll to top